| 第1型糖尿病 | type 1 diabetes |
| 第2型糖尿病 | type 2 diabetes |
| 妊娠性糖尿病 | gestational diabetes mellitus；GDM |
| 糖化血色素 | glycosylated hemoglobin；HbA1C |
| 口服降血糖藥劑 | oral hypoglycemic agents；OHA |
| 酮酸中毒 | diabetic ketoacidosis；DKA |
| 高滲透壓性高血糖狀態 | hyperosmolar hyperglycemic state；HHS |
| 高滲透壓高血糖非酮酸性昏迷 | hyperosmolar, hyperglycemic nonketotic syndrome；HHNK |
| 胰島素抗性 | insulin resistance |
| 代謝症候群 | metabolic syndrome |
| 胰島素抗性症候群 | insulin resistance syndrome |
| 糖尿病前期 | pre-diabetes |
| 血糖自我監視 | self-monitoring of blood glucose；SMBG |
| 反應性低血糖 | reactive hypoglycemia |
| 進葡萄糖載體 | glucose transporter |
| 胰島細胞抗體 | islet cell autoantibodies；ICAs |
| 胰島素抗體 | autoantibodies to insulin；IAAs |
| 麩胺基酸抗體 | autoantibodies to glutamic acid decarboxylase；GAD |
| 初期胰島素抗性 | insulin resistance |
| 胰島素抗性症候群 | insulin resistance syndrome |
| 代謝症候群 | metabolic syndrome |
| X症候群 | syndrome X |
| 胰島細胞功能缺陷 | genetic defects of β-cell function |
| 為年輕發作成年型糖尿病 | maturity-onset diabetes of the young；MODY |
| 胰島素作用異常 | genetic defects in insulin action |
| 胎盤荷爾蒙 | placental hormones |
| 黃體酮 | progesterone |
| 空腹血漿血糖值 | fasting plasma glucose；FPG |
| 口服葡萄糖耐量試驗 | oral glucose tolerance test；OGTT |
| 空腹血糖 | fasting plasma glucose |
| 空腹血漿血糖值異常 | impaired fasting glucose； IFG |
| 葡萄糖耐受異常 | impaired glucose tolerance；IGT |
| 葡萄糖耐受異常者 | glucose intolerance |
| 國際糖尿病與妊娠研究協會 | International Association of Diabetes and Pregnancy Study Groups；IADPSG |
| 糖尿病預防研究 | Diabetes Prevention Study |
| 葡萄糖耐量減低 | impaired glucose tolerence |
| 介入組 | intervention group |
| 控制組 | control group |
| 無預警性低血糖 | unawareness hypoglycemia |
| 糖尿病控制 | Diabetes Control |
| 併發症試驗 | Complications Trial |
| 自我監測血糖 | self-monitoring of blood glucose；SMBG |
| 自我管理 | self-management |
| 醫療營養治療 | medical nutrition therapy；MNT |
| 胰島素阻抗 | insulin resistance |
| 地中海飲食 | mediterranean diets |
| 理想體重 | ideal body weight；IBWkg |
| 熱量 | energy expenditure；EE |
| 活動因素 | activity factor |
| 壓力因素 | stress factor |
| 快速吸收的糖 | fastacting carbohydrate |
| 升糖反應 | glycemic responeses |
| 升糖指數 | glycemic index for selected foods；GI |
| 輕度低血糖 | mild hypoglycemia |
| 極低密度脂蛋白； VLDL | very-low-density lipoproteins；VLDL |
| 滲透性腹瀉 | osmotic diarrhea |
| 美國食品藥物管理局 | Food and Drug Administration；FDA |
| 可接受的每日攝入量； ADI | acceptable daily intake；ADI |
| 益富鎂適甜代糖 | hermesetas gold |
| 三多甜代糖 | sentosa tame-L |
| 思維樂低熱量糖 | sweetn low |
| 怡口健康糖 | equal |
| 有益富煮甜甜 | hermesetas |
| 思維樂熱甜甜 | sweetn low |
| 的膳食纖維 | dietary fiber |
| 醣類耐受不良 | carbohydrate intolerance |
| 酒精當量 | standard drink |
| 食物代換 | exchange lists for meal planning。 |
| 高醣類高纖維飲食 | the high carbohydrate-high fiber；HCF |
| 熱量點數計算 | calorie point counting |
| 脂肪計算 | fat counting |
| 醣類計算 | carbohydrate counting |
| 總葡萄糖量值 | total available glucose；TAG |
| 逐步治療 | stepwise treatment |
| 胰島澱粉樣多肽激動劑 | Amylin agonists |
| GLP-1受體激動劑 | GLP-1 Receptor agonists |
| 皮下繼續輸注法 | continuous subcutaneous insulin infusion；CSII。 |
| 健康飲食 | healthy eating |
| 健康體能 | being active |
| 監測 | monitoring |
| 接受治療 | taking medication |
| 解決問題 | problem solving |
| 善處健康 | healthy coping |
| 減少風險 | reducing risks |
| 腎絲球過濾率 | glomerular filtration rate；GFR |
| 高滲透壓高血糖非酮酸性昏迷 | hyperosmolar hyperglycemic non-ketotic syndrome；HHNK |
| 梭莫基效應 | the somogyi effect |
| 拮抗荷爾蒙 | counterregulatory hormones |
| 黎明現象 | the dawn phenomenon |
| 反應性低血糖 | reactive hypoglycemia |
| 餐後症候群 | postprandial syndrome |
| 非胰島素瘤胰源性低血糖症候群 | noninsulinoma pancreatogeneous hypoglycemia syndrome |
| 美格替尼 | Meglitinides |
| α-葡萄糖抑制劑 | α-Glucosidase Inhibitor |
| 二肽基酶-4抑制劑 | DPP-IV Inhibitor |
| 葡萄糖共轉運蛋白2SGLT2抑製劑 | sodium glucose co-transporter 2 SGLT2 inhibitors |
字體：小 中 大
